MEDICINAL SPECIALTIES
Innovation, quality, and experience at the service of health
At Triquim we develop and manufacture Medicinal Specialties under the highest quality standards, combining scientific experience, state-of-the-art technology and a solid commitment to excellence.
Each product is the result of an integral process that prioritizes safety, efficacy and compliance with national and international regulations, allowing us to offer reliable solutions for the pharmaceutical industry and contribute to the well-being of patients.
Technical Excellence & Regulatory Support
Our multidisciplinary team works with a comprehensive approach to guarantee that each Medicinal Specialty meets the highest quality requirements and the regulatory demands of the markets where our clients operate.
We have a highly specialized Regulatory Affairs Department, responsible for developing and maintaining solid and updated technical documentation, providing the necessary support to accompany the registration and commercialization processes of each product.
The combination of technical experience, scientific rigor and regulatory knowledge allows us to offer reliable solutions, tailored to the needs of each project and aligned with international standards.
Medicinal Specialties Catalog
Medicines and pharmaceutical specialties developed under rigorous quality standards and international regulatory compliance.
| # | Product / Active Ingredient | Therapeutic Action / Indication | Concentration / Form | Action |
|---|---|---|---|---|
| 01 | Sugammadex | Reversal of neuromuscular blockade induced by Rocuronium or Vecuronium / Anesthesia | 100 mg/ml / Injectable solution | Inquire |
| 02 | Remifentanil | Opioid receptor agonist / Anesthesia | 5 mg / Lyophilized powder for injection | Inquire |
| 03 | Fentanyl | Opioid receptor agonist / Potent analgesia | 0.25 mg / 5 ml / Injectable solution | Inquire |
| 04 | Rocuronium Bromide | Neuromuscular blocker / Anesthesia | 50 mg / 5 ml / Injectable solution | Inquire |
| 05 | Vecuronium Bromide | Neuromuscular blocker / Anesthesia | 10 mg / Lyophilized powder for injection | Inquire |
| 06 | Remimazolam | Ultra-short acting benzodiazepine / Sedation | 20 mg / Lyophilized powder for injection | Inquire |
| 07 | Ondansetron | Serotonin 5-HT3 receptor antagonist / Antiemetic | 4 and 8 mg / Injectable solution | Inquire |
| 08 | Ondansetron | Serotonin 5-HT3 receptor antagonist / Antiemetic | 4 and 8 mg / Coated tablets | Inquire |
| 09 | Dexmedetomidine | Alpha-2 adrenergic receptor agonist / Sedoanalgesia | 100 mg/ml / Injectable solution | Inquire |
| 10 | Apixaban | Antithrombotic agent, direct Factor Xa inhibitor | 2.5 and 5 mg / Coated tablets | Inquire |
| 11 | Prasugrel | Platelet aggregation inhibitor / Prevention of atherothrombotic events | 5 and 10 mg / Coated tablets | Inquire |
| 12 | Selexipag | Platelet aggregation inhibitor / Pulmonary arterial hypertension | 0.2 - 0.4 and 0.8 mg / Coated tablets | Inquire |
| 13 | Manidipine | Calcium channel blocker / Hypertension | 10 and 20 mg / Tablets | Inquire |
| 14 | Dapagliflozin | SGLT2 inhibitor / Type 2 diabetes | 10 mg / Coated tablets | Inquire |
| 15 | Empagliflozin | SGLT2 inhibitor / Type 2 diabetes | 10 and 25 mg / Coated tablets | Inquire |
Portfolio in different stages of registration and launch — please inquire for availability by product and country.
Pharmacovigilance
At Triquim we understand that our commitment to quality continues once the product reaches the market.
Our Pharmacovigilance system allows us to receive, evaluate and manage information related to the safety of our Medicinal Specialties, ensuring continuous monitoring of their benefit-risk profile and promoting the permanent improvement of our products.
Pharmacovigilance Contact
